Pathogenesis and management of bone lesions in multiple myeloma (Q41460446)

1 October 2017

1 reference

title

Pathogenesis and management of bone lesions in multiple myeloma (English)

1 reference

1 October 2017

Bataille R

1

1 reference

1 October 2017

Manolagas SC

series ordinal

2

1 reference

1 October 2017

Berenson JR

series ordinal

3

1 reference

1 October 2017

language of work or name

1 reference

1 April 1997

1 reference

Hematology / Oncology Clinics of North America

1 October 2017

published in

1 reference

1 October 2017

volume

11

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

349-361

1 reference

Ineffectiveness of Fluoride Therapy in Multiple Myeloma

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Detection of Interleukin-1β and Interleukin-6 in Human Multiple Myeloma by Fluorescent in situ Hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Osteoblast stimulation in multiple myeloma lacking lytic bone lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Abnormal serum bone Gla protein levels in multiple myeloma. Crucial role of bone formation and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Serum bone gla-protein in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Acute effects of salmon calcitonin in multiple myeloma: a valuable method for serial evaluation of osteoclastic lesions and disease activity--a prospective study of 125 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Importance of quantitative histology of bone changes in monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Effect of daily etidronate on the osteolysis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Osteoclast cytomorphometry demonstrates an abnormal population in B cell malignancies but not in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

The biology of interleukin 1 and comparison to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Interleukin-11: a new cytokine critical for osteoclast development

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Increased osteoclast development after estrogen loss: mediation by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Multiple-myeloma bone disease. The comparative effect of sodium fluoride and calcium carbonate or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Bisphosphonates: a review of their pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Human osteoblastlike cells do not respond to interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Use of pamidronate for multiple myeloma osteolytic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

The many facets of multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Bone-Resorbing Activity in Supernatants from Lymphoid Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Bisphosphonates: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Interleukin-6: an osteotropic factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Production of parathyroid hormone-related protein by cultured human myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Role of colony-stimulating factors in osteoclast development.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Treatment of bone metastases from breast cancer and myeloma with pamidronate.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Quantitative histology of myeloma-induced bone changes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970435-4

7 January 2021

10.1016/S0889-8588(05)70435-4

Identifiers

DOI

1 reference

1 October 2017

1 reference